6533b7dbfe1ef96bd127133b
RESEARCH PRODUCT
Management of Osteoporosis in Postmenopausal Women
Juan José Hidalgo-moraA. Cano-marquinaAnna SzeligaAntonio CanoMiguel Angel García-pérezsubject
musculoskeletal diseasesmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentOsteoporosisEstrogen receptorDiseasemedicine.diseaseBone remodelingResorptionMenopauseEndocrinologymedicine.anatomical_structureInternal medicinemedicineBone marrowHormone therapybusinessdescription
Osteoporosis is a noncommunicable disease with increasing incidence at a global level. The burden of the disease particularly concerns women. A drastic and rapid decline in the circulating levels of estrogens, a key regulator of bone metabolism, is responsible for the increase in bone loss after menopause. Cells with a role in bone metabolism, osteoblasts, osteoclasts and osteocytes, have estrogen receptors. The fall in estrogens increases the differentiation of osteoclasts from progenitors in the bone marrow. A significant expansion in the resorption process follows.
year | journal | country | edition | language |
---|---|---|---|---|
2019-01-01 |